Cargando…
Research of Pathogenesis and Novel Therapeutics in Arthritis
Arthritis has a high prevalence globally and includes over 100 types, the most common of which are rheumatoid arthritis, osteoarthritis, psoriatic arthritis and inflammatory arthritis. The exact etiology of arthritis remains unclear and no cure exists. Anti-inflammatory drugs are commonly used in th...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479975/ https://www.ncbi.nlm.nih.gov/pubmed/30987068 http://dx.doi.org/10.3390/ijms20071646 |
_version_ | 1783413469417046016 |
---|---|
author | Tang, Chih-Hsin |
author_facet | Tang, Chih-Hsin |
author_sort | Tang, Chih-Hsin |
collection | PubMed |
description | Arthritis has a high prevalence globally and includes over 100 types, the most common of which are rheumatoid arthritis, osteoarthritis, psoriatic arthritis and inflammatory arthritis. The exact etiology of arthritis remains unclear and no cure exists. Anti-inflammatory drugs are commonly used in the treatment of arthritis, but are associated with significant side effects. Novel modes of therapy and additional prognostic biomarkers are urgently needed for these patients. In this editorial, the twenty articles published in the Special Issue Research of Pathogenesis and Novel Therapeutics in Arthritis 2019 are summarized and discussed as part of the global picture of the current understanding of arthritis. |
format | Online Article Text |
id | pubmed-6479975 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-64799752019-04-29 Research of Pathogenesis and Novel Therapeutics in Arthritis Tang, Chih-Hsin Int J Mol Sci Editorial Arthritis has a high prevalence globally and includes over 100 types, the most common of which are rheumatoid arthritis, osteoarthritis, psoriatic arthritis and inflammatory arthritis. The exact etiology of arthritis remains unclear and no cure exists. Anti-inflammatory drugs are commonly used in the treatment of arthritis, but are associated with significant side effects. Novel modes of therapy and additional prognostic biomarkers are urgently needed for these patients. In this editorial, the twenty articles published in the Special Issue Research of Pathogenesis and Novel Therapeutics in Arthritis 2019 are summarized and discussed as part of the global picture of the current understanding of arthritis. MDPI 2019-04-02 /pmc/articles/PMC6479975/ /pubmed/30987068 http://dx.doi.org/10.3390/ijms20071646 Text en © 2019 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Editorial Tang, Chih-Hsin Research of Pathogenesis and Novel Therapeutics in Arthritis |
title | Research of Pathogenesis and Novel Therapeutics in Arthritis |
title_full | Research of Pathogenesis and Novel Therapeutics in Arthritis |
title_fullStr | Research of Pathogenesis and Novel Therapeutics in Arthritis |
title_full_unstemmed | Research of Pathogenesis and Novel Therapeutics in Arthritis |
title_short | Research of Pathogenesis and Novel Therapeutics in Arthritis |
title_sort | research of pathogenesis and novel therapeutics in arthritis |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479975/ https://www.ncbi.nlm.nih.gov/pubmed/30987068 http://dx.doi.org/10.3390/ijms20071646 |
work_keys_str_mv | AT tangchihhsin researchofpathogenesisandnoveltherapeuticsinarthritis |